Position in NBIX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$61,519,549
-$3,605,381 QoQ
Shares Held
466,977
+1.7% QoQ
Ownership
0.464%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 94.11341457930476.ToString("F0")%
None 5.886585420695237.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $1,320,238,974 across 27 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,701,747 | $437,583,511 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
4,774,841 | $362,171,687 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,816,657 | $145,077,707 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
8,908,506 | $84,808,976 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
4,986,073 | $69,306,414 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
466,977 | $61,519,549 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,825,651 | $60,374,277 | |
| 8 | BIOA |
BioAge Labs, Inc.
|
2,094,270 | $36,628,782 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,519,549 | 466,977 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $65,124,930 | 459,176 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $83,549,964 | 595,170 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $97,544,237 | 776,070 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $86,706,639 | 783,966 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $108,397,107 | 794,118 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $91,276,822 | 792,196 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $133,705,516 | 971,203 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $190,124,511 | 1,378,513 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $204,408,114 | 1,551,367 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $193,168,574 | 1,717,054 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $180,003,988 | 1,908,844 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $201,885,414 | 1,994,521 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $288,523,801 | 2,415,638 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $523,279,037 | 4,926,834 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $508,234,788 | 5,213,734 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $591,540,279 | 6,309,763 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $634,162,107 | 7,445,839 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $861,877,088 | 8,986,311 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $871,215,841 | 8,952,074 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $897,742,855 | 9,231,289 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $878,095,364 | 9,161,141 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $629,693,470 | 6,548,393 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $792,291,302 | 6,494,191 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $660,307,173 | 7,629,199 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||